The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-Cells
Abstract
A number of studies have shown pharmacologic evidence indicating that stimulation of type I dopamine receptor (DRs), favours T-helper-17 (Th17)-mediated immunity involved in experimental autoimmune encephalomyelitis (EAE) and in some other inflammatory disorders. Nevertheless, the lack of drugs that might discriminate between DRD1 and DRD5 has made the pharmacological distinction between the two receptors difficult. We have previously shown genetic evidence demonstrating a relevant role of DRD5-signalling in dendritic cells (DCs) favouring the CD4+ T-cell-driven inflammation in EAE. However, the role of DRD5-signalling confined to CD4+ T-cells in the development of EAE is still unknown. Here, we analysed the functional role of DRD5-signalling in CD4+ T-cell-mediated responses and its relevance in EAE by using a genetic approach. Our results show that DRD5-signalling confined to naive CD4+ T-cells exerts a pro-inflammatory effect promoting the development of EAE with a stronger disease severity. This pro-inflammatory effect observed for DRD5-signalling in naive CD4+ T-cells was related with an exacerbated proliferation in response to T-cell activation and to an increased ability to differentiate toward the Th17 inflammatory phenotype. On the other hand, quite unexpected, our results show that DRD5-signalling confined to Tregs strengthens their suppressive activity, thereby dampening the development of EAE manifestation. This anti-inflammatory effect of DRD5-signalling in Tregs was associated with a selective increase in the expression of glucocorticoid-induced tumour necrosis factor receptor-related protein (GITR), which has been described to play a critical role in the expansion of Tregs. Our findings here indicate a complex role for DRD5-signalling in CD4+ T-cells-driven responses potentiating early inflammation mediated by effector T-cells in EAE, but exacerbating suppressive activity in Tregs and thereby dampening disease manifestation in late EAE stages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1716 · Cited by 1,206
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome
Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R. (2015) · Cell · doi:10.1016/j.cell.2014.11.047 · Cited by 1,014
Kim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856 · cited 2×
“, 2012) and CD4 T-cells from human and mouse origin (Kipnis et al., 2004; Cosentino et al., 2007; Kim et al., 2013; Franz et al., 2015).”
BackgroundAsano, Y., Hiramoto, T., Nishino, R., Aiba, Y., Kimura, T., Yoshihara, K., Koga, Y., & Sudo, N. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00341.2012 · Cited by 659
Clark, A., & Mach, N. (2016) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-016-0155-6 · Cited by 583 · cited 1×
“…indicating that some components of gut microbiota, including Bacillus cereaus, Bacillus mycoides, Bacillus subtilis, Proteus vulgaris, Serratia marcescens, S. aureus, E. coli K-12, Morganella morganii, Klebisella pneumoniae and Hafnia alvei, can also produce dopamine (Clark and Mach, 2016).”
BackgroundActivation of the reward system boosts innate and adaptive immunity
Ben-Shaanan, T. L., Azulay-Debby, H., Dubovik, T., Starosvetsky, E., Korin, B., Schiller, M., Green, N. L., Admon, Y., Hakim, F., Shen-Orr, S. S., et al. (2016) · Nature Medicine · doi:10.1038/nm.4133 · Cited by 272
Wu, W., Sun, M., Zhang, H.-P., Chen, T., Wu, R., Liu, C., Yang, G., Geng, X.-R., Feng, B.-S., Liu, Z., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306083 · Cited by 93
Research works printed but not linked: 48
- Balkowiec-Iskra, 2007, Dopamine, serotonin and noradrenaline changes in the striatum of C57BL mice following myelin oligodendrocyte glycoprotein (MOG) 35–55 and complete Freund adjuvant (CFA) administration, Acta Neurobiol. Exp., 67, 379, 10.55782/ane-2007-1655 · DOI
- Berer, 2017, Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice, Proc. Natl. Acad. Sci. U S A, 114, 10719, 10.1073/pnas.1711233114 · DOI · Paper page
- Bourne, 2001, SCH 23390: the first selective dopamine D1-like receptor antagonist, CNS Drug Rev., 7, 399, 10.1111/j.1527-3458.2001.tb00207.x · DOI · Paper page
- Contreras, 2016, Dopamine receptor D3 signaling on CD4+ T cells favors Th1- and Th17-mediated immunity, J. Immunol., 196, 4143, 10.4049/jimmunol.1502420 · DOI
- Cosentino, 2007, Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop, Blood, 109, 632, 10.1182/blood-2006-01-028423 · DOI · Paper page
- Cosentino, 2012, Dopaminergic modulation of CD4+CD25 regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy, Neuroimmunomodulation, 19, 283, 10.1159/000336981 · DOI
- Dardalhon, 2008, Role of Th1 and Th17 cells in organ-specific autoimmunity, J. Autoimmun., 31, 252, 10.1016/j.jaut.2008.04.017 · DOI · Paper page
- Ehringer, 1960, Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system, Klin. Wochenschr., 38, 1236, 10.1007/BF01485901 · DOI · Paper page
- Fernández, 2016, Purinergic signaling as a regulator of Th17 cell plasticity, PLoS One, 11, e0157889, 10.1371/journal.pone.0157889 · DOI
- Franz, 2015, Dopamine receptors D3 and D5 regulate CD4+T-cell activation and differentiation by modulating ERK activation and cAMP production, J. Neuroimmunol., 284, 18, 10.1016/j.jneuroim.2015.05.003 · DOI
- Gong, 2013, Blockade of dopamine D1-like receptor signaling protects mice against OVA-induced acute asthma by inhibiting B-cell activating transcription factor signaling and Th17 function, FEBS J., 280, 6262, 10.1111/febs.12549 · doi:10.1111/febs.12549
- González, 2013, Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson’s disease, J. Immunol., 190, 5048, 10.4049/jimmunol.1203121 · DOI
- Haines, 2013, Autoimmune memory T helper 17 cell function and expansion are dependent on interleukin-23, Cell Rep., 3, 1378, 10.1016/j.celrep.2013.03.035 · DOI
- Hashimoto, 2009, Dopamine D1-like receptor antagonist, SCH23390, exhibits a preventive effect on diabetes mellitus that occurs naturally in NOD mice, Biochem. Biophys. Res. Commun., 383, 460, 10.1016/j.bbrc.2009.04.034 · DOI
- Haskó, 1998, Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system, Biochem. Pharmacol., 56, 1079, 10.1016/s0006-2952(98)00153-1 · DOI · Paper page
- Hollon, 2002, Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive, J. Neurosci., 22, 10801, 10.1523/JNEUROSCI.22-24-10801.2002 · DOI · Paper page
- Inaba, 1992, Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor, J. Exp. Med., 176, 1693, 10.1084/jem.176.6.1693 · DOI · Paper page
- Kim, 2008, The role of GM-CSF in adipose tissue inflammation, Am. J. Physiol. Endocrinol. Metab., 295, E1038, 10.1152/ajpendo.00061.2008 · DOI
- Kipnis, 2004, Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration, J. Neurosci., 24, 6133, 10.1523/JNEUROSCI.0600-04.2004 · DOI · Paper page
- Lee, 2012, Induction and molecular signature of pathogenic TH17 cells, Nat. Immunol., 13, 991, 10.1038/ni.2416 · DOI · Paper page
- Li, 2014, Th2 lymphocytes migrating to the bone marrow under high-altitude hypoxia promote erythropoiesis via activin A and interleukin-9, Exp. Hematol., 42, 804, 10.1016/j.exphem.2014.04.007 · DOI
- Logan, 2013, TGF-β superfamily gene expression and induction of the Runx1 transcription factor in adult neurogenic regions after brain injury, PLoS One, 8, e59250, 10.1371/journal.pone.0059250 · DOI
- Magro, 2006, Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment, Dig. Dis. Sci., 51, 2039, 10.1007/s10620-006-9168-3 · DOI
- Magro, 2004, Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-γ upon L-DOPA uptake, Acta Physiol. Scand., 180, 379, 10.1111/j.1365-201x.2004.01260.x · DOI
- Magro, 2002, Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease, Dig. Dis. Sci., 47, 216, 10.1023/A:1013256629600 · DOI · Paper page
- Nakagome, 2011, Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and ovalbumin antigen-induced neutrophilic airway inflammation, J. Immunol., 186, 5975, 10.4049/jimmunol.1001274 · DOI
- Nakano, 2008, Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis, Biochem. Biophys. Res. Commun., 373, 286, 10.1016/j.bbrc.2008.06.012 · DOI
- Nakano, 2009, Dopamine released by dendritic cells polarizes Th2 differentiation, Int. Immunol., 21, 645, 10.1093/intimm/dxp033 · DOI
- Nakano, 2011, Dopamine induces IL-6-dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model, J. Immunol., 186, 3745, 10.4049/jimmunol.1002475 · DOI · Paper page
- Nakashioya, 2011, Therapeutic effect of D1-like dopamine receptor antagonist on collagen-induced arthritis of mice, Mod. Rheumatol., 21, 260, 10.1007/s10165-010-0387-2 · doi:10.1007/s10165-010-0387-2
- O’Connor, 2013, T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease, Eur. J. Immunol., 43, 2818, 10.1002/eji.201343689 · DOI
- Okada, 2009, D1-like receptor antagonist inhibits IL-17 expression and attenuates crescent formation in nephrotoxic serum nephritis, Am. J. Nephrol., 30, 274, 10.1159/000225902 · DOI
- Oukka, 2008, Th17 cells in immunity and autoimmunity, Ann. Rheum. Dis., 67, iii26, 10.1136/ard.2008.098004 · DOI
- Pacheco, 2017, Targeting dopamine receptor D3 signaling in inflammation, Oncotarget, 8, 7224, 10.18632/oncotarget.14601 · DOI
- Pacheco, 2014, The dopaminergic system in autoimmune diseases, Front. Immunol., 5, 117, 10.3389/fimmu.2014.00117 · DOI · Paper page
- Papa, 2017, TFH-derived dopamine accelerates productive synapses in germinal centres, Nature, 547, 318, 10.1038/nature23013 · DOI · Paper page
- Peng, 2014, Interleukin-22 promotes T helper 1 (Th1)/Th17 immunity in chlamydial lung infection, Mol. Med., 20, 109, 10.2119/molmed.2013.00115 · doi:10.2119/molmed.2013.00115
- Petermann, 2010, γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism, Immunity, 33, 351, 10.1016/j.immuni.2010.08.013 · DOI · Paper page
- Prado, 2013, Modulation of T-cell mediated immunity by dopamine receptor d5, Endocr. Metab. Immune Disord Drug Targets, 13, 184, 10.2174/1871530311313020007 · DOI
- Prado, 2012, Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity, J. Immunol., 188, 3062, 10.4049/jimmunol.1103096 · DOI · Paper page
- Prado, 2018, Dopaminergic stimulation of myeloid antigen-presenting cells attenuates signal transducer and activator of transcription 3-activation favoring the development of experimental autoimmune encephalomyelitis, Front. Immunol., 9, 571, 10.3389/fimmu.2018.00571 · DOI · Paper page
- Ronchetti, 2015, Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells, J. Immunol. Res., 2015, 171520, 10.1155/2015/171520 · DOI
- Shao, 2013, Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin, Nature, 494, 90, 10.1038/nature11748 · DOI · Paper page
- Smeltz, 1999, Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity, J. Immunol., 163, 1390, 10.4049/jimmunol.163.3.1390 · DOI
- Ureta, 2007, Generation of dendritic cells with regulatory properties, Transplant. Proc., 39, 633, 10.1016/j.transproceed.2006.12.032 · DOI
- Wang, 2014, The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-γ-producing T helper 17 cells, Immunity, 40, 355, 10.1016/j.immuni.2014.01.002 · DOI · Paper page
- Weihe, 1991, Molecular anatomy of the neuro-immune connection, Int. J. Neurosci., 59, 1, 10.3109/00207459108985446 · DOI · Paper page
- Yin, 2013, Nuclear export factor 3 is involved in regulating the expression of TGF-β3 in an mRNA export activity-independent manner in mouse Sertoli cells, Biochem. J., 452, 67, 10.1042/BJ20121006 · doi:10.1042/bj20121006
Cited by
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Metadata
- Authors
- Osorio-Barrios, F., Prado, C., Contreras, F., & Pacheco, R.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2018-07-10
- Volume
- 12
- ISSN
- 1662-5102
- Cited by
- 41
- References
- 8
- Funders
- Comisión Nacional de Investigación Científica y Tecnológica (AFB170004)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.